Romania’s pharma market grows but not in volume
<p>Medicines sales increased in Romania by 15.5% y/y to RON 8.15 billion (EUR 1.64 billion) in Q1, but they decreased in volume terms (boxes) by 2.8%, according to market research company Cegedim, quoted by <a href="https://www.zf.ro/zf-24/cegedim-piata-medicamente-crescut-ultimele-12-luni-15-9-31-miliarde-22371214?mc_cid=51fb4789bb&amp;mc_eid=cd1f92f96c" rel="noopener" target="_blank">Ziarul Financiar</a>.&nbsp;</p>

<p>The retail prices of medicines increased by 17.7% y/y in Q1, more than twice the average inflation (7.1% y/y), according to the statistics office INS.</p>

<p>The market’s negative dynamics in volume terms were generated both by the retail segment (-2.9%) as well as by the hospital segment, which decreased at a slower rate (-0.2%).</p>

<p>In the period April 2023 - March 2024, the total value of the medicines market was RON 31.06 billion (EUR 6.26 billion), up 15.9% y/y.&nbsp;</p>

<p>Regarding the main suppliers on the local market, for the period April 2023 - March 2024, Sun Pharma (including Terapia) ranks as the largest with RON 1.45 billion, followed by Sanofi with RON 1.44 billion and AstraZeneca with RON 1.41 billion.</p>

<p><em>iulian@romania-insider.com</em></p>

<p><em>(Photo source: <a href="https://www.dreamstime.com/" rel="noopener" target="_blank">Serhii Bobyk/Dreamstime.com</a>)</em></p>